Molina Healthcare vs UnitedHealth
MOH and UNH side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MOH and UNH compare
UnitedHealth is the larger company, worth 34 times as much as Molina Healthcare ($365B against $10.7B).
UnitedHealth grew revenue faster over the last twelve months (6.5% versus 2.6% for Molina Healthcare).
UnitedHealth keeps more of each dollar of sales as profit, with a net margin of 3.1% compared with −0.02% at Molina Healthcare.
UnitedHealth pays a dividend yielding 2.2%; Molina Healthcare does not pay one.
UnitedHealth scores higher on the StockData Score (11 against 5 for Molina Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MOH | UNH |
|---|---|---|
| Size and price | ||
| Market cap | $10.7B | $365B |
| Share price | $204.78 | $406.97 |
| Change, 1 year | 27.8% | 14.6% |
| Change, 5 years | −32.7% | −10.7% |
| Beta (5Y) | 0.25 | 0.32 |
| Employees | 19K | 390K |
| StockData Score | ||
| Total score | 5 | 11 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 2 | 2 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 26.2× |
| P/S | 0.2× (better) | 0.8× |
| P/B | 2.6× | – |
| EV/EBITDA | 14.9× (better) | 15.9× |
| P/FCF | 39.4× | 15.5× (better) |
| FCF yield | 2.5% | 6.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 2.6% | 6.5% (better) |
| Revenue growth, 5Y average | 18.5% (better) | 11.7% |
| Net income growth (TTM) | −101% | −33.7% (better) |
| EPS growth (TTM) | −101% | −32.7% (better) |
| EPS growth, 5Y average | −4.5% | −3.8% (better) |
| Profitability | ||
| Gross margin | 12.6% | 88.6% (better) |
| Operating margin | 0.46% | 4.8% (better) |
| Net margin | −0.02% | 3.1% (better) |
| FCF margin | 0.61% | 5.2% (better) |
| Return on equity | −0.16% | – |
| Financial health | ||
| Debt / equity | 0.90 | – |
| Net debt / EBITDA | −13.87 | 1.61 (better) |
| Interest coverage | 1.0× | 5.6× (better) |
| Current ratio | 1.68 (better) | 0.78 |
| Altman Z-score | 4.08 (better) | 3.12 |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 2.2% |
| Payout ratio | – | 57.3% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 12.6% |
| Buyback yield | 4.7% (better) | 0.28% |
| Shareholder yield | 4.7% (better) | 2.5% |
| Ownership | ||
| Held by institutions | 108% | 87.7% |
| Held by insiders | 1.5% | 0.18% |
| Insider net buying, 12 months | −$3.5M | −$945K (better) |
| Superinvestors holding | 2 | 8 (better) |
| Short interest, % of float | 5.6% | 1.8% |
Go deeper
- MOH stock overview
- MOH income statement
- MOH valuation and score
- UNH stock overview
- UNH income statement
- UNH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.